Effects of Zortress® + Tacrolimus vs. Standard Immunosuppression on Progression of Coronary Artery Calcifications and Bone Disease in de Novo Renal Transplant Recipients

Share this content:
Effects of Zortress® + Tacrolimus vs. Standard Immunosuppression on Progression of Coronary Artery Calcifications and Bone Disease in de Novo Renal Transplant Recipients

Sponsors and Collaborators
University of Kentucky

Contact
Hartmut Malluche, MD
8593235049
hhmall@uky.edu

Roberto Gedaly, MD
8593234661
rgeda2@uky.edu

Principal Investigators
Hartmut Malluche, MD, University of Kentucky
Roberto Gedaly, MD, University of Kentucky

ClinicalTrials.gov Identifier
NCT01612299

You must be a registered member of Renal and Urology News to post a comment.

Sign Up for Free e-newsletters